CD19+ lineage chimerism, an early biomarker after anti-CD19 CAR-T cell therapy in patients previously receiving a hematopoietic stem cell transplantation

Autor: Isabel Martínez-Romera, Víctor Galán-Gómez, Berta González-Martínez, Pilar Guerra García, Sonsoles San Román Pacheco, Dolores Corral Sánchez, Yasmina Mozo del Castillo, David Bueno Sánchez, Luisa Sisinni, Alba González Guerrero, Serafin Castellano Dámaso, Elena Sánchez Zapardiel, Beatriz Ruz Caracuel, Antonio Balas Pérez, Antonio Pérez-Martínez

Publikováno v: Frontiers in Immunology, Vol 13 (2022)

Treatment targeting CD19 by a chimeric antigen receptor expressed on T cells (anti-CD19 CAR-T) has led to a breakthrough in the management and treatment of relapsed and refractory B- cell acute lymphoblastic leukemia (B-ALL). After infusion, the effi

Externí odkaz: https://doaj.org/article/ce2688322ec946c8a6d1777dae270900

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Improved donor chimerism in relapse myelofibrosis post allogenic stem cell transplant with azacitidine and oral decitabine-First case report.

Autor: Cheung V; Princess Margaret Cancer Centre Toronto Ontario Canada.; University of Toronto Toronto Ontario Canada., Michelis FV; Hans Messner Allogeneic Transplant Program Princess Margaret Cancer Centre, University Health Network Toronto ON Canada., Sibai H; Princess Margaret Cancer Centre Toronto Ontario Canada.; University of Toronto Toronto Ontario Canada.

Publikováno v: EJHaem [EJHaem] 2022 Nov 16; Vol. 4 (1), pp. 269-272. Date of Electronic Publication: 2022 Nov 16 (Print Publication: 2023).